Structure-activity relationship for the folding intermediate-selective inhibition of DYRK1A

被引:6
|
作者
Miyazaki, Yuka [1 ]
Kikuchi, Masaki [2 ]
Umezawa, Koji [3 ]
Descamps, Aurelie [4 ]
Nakamura, Daichi [4 ]
Furuie, Gaku [1 ]
Sumida, Tomoe [4 ,6 ]
Saito, Kanako [1 ]
Kimura, Ninako [1 ]
Niwa, Takashi [4 ]
Sumida, Yuto [4 ,6 ]
Umehara, Takashi [2 ]
Hosoya, Takamitsu [4 ,5 ]
Kii, Isao [1 ,3 ,4 ]
机构
[1] Shinshu Univ, Grad Sch Sci & Technol, Dept Agr, Lab Drug Target Res, 8304 Minami Minowa, Nagano 3994598, Japan
[2] RIKEN, Lab Epigenet Drug Discovery, Ctr Biosyst Dynam Res, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan
[3] Shinshu Univ, Inst Biomed Sci, Dept Biomol Innovat, 8304 Minami Minowa, Nagano 3994598, Japan
[4] RIKEN, Lab Chem Biol, Ctr Biosyst Dynam Res, Chuo Ku, 6-7-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan
[5] Tokyo Med & Dent Univ TMDU, Inst Biomat & Bioengn, Lab Chem Biosci, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo, Japan
[6] Kanazawa Univ, Grad Sch Med Sci, Div Pharmaceut Sci, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan
关键词
DYRK1A; Folding intermediate; Autophosphorylation; FINDY; Alzheimer's disease; Down syndrome; DOWN-SYNDROME CANDIDATE; PROTEIN-KINASE; MOUSE MODEL; MURINE MODEL; DRUG-TARGET; CYCLIN D1; ACTIVATION; AUTOPHOSPHORYLATION; OVEREXPRESSION; REVEALS;
D O I
10.1016/j.ejmech.2021.113948
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
DYRK1A phosphorylates proteins involved in neurological disorders in an intermolecular manner. Meanwhile, during the protein folding process of DYRK1A, a transitional folding intermediate catalyzes the intramolecular autophosphorylation required for the "one-off" inceptive activation and stabilization. In our previous study, a small molecule termed FINDY (1) was identified, which inhibits the folding intermediate-catalyzed intramolecular autophosphorylation of DYRK1A but not the folded state-catalyzed intermolecular phosphorylation. However, the structural features of FINDY (1) responsible for this intermediate-selective inhibition remain elusive. In this study, structural derivatives of FINDY (1) were designed and synthesized according to its predicted binding mode in the ATP pocket of DYRK1A. Quantitative structure-activity relationship (QSAR) of the derivatives revealed that the selectivity against the folding intermediate is determined by steric hindrance between the bulky hydrophobic moiety of the derivatives and the entrance to the pocket. In addition, a potent derivative 3 was identified, which inhibited the folding intermediate more strongly than FINDY (1); it was designated as dp-FINDY. Although dp-FINDY (3) did not inhibit the folded state, as well as FINDY (1), it inhibited the intramolecular autophosphorylation of DYRK1A in an in vitro cell-free protein synthesis assay. Furthermore, dp-FINDY (3) destabilized endogenous DYRK1A in HEK293 cells. This study provides structural insights into the folding intermediate-selective inhibition of DYRK1A and expands the chemical options for the design of a kinase inhibitor. (C) 2021 Elsevier Masson SAS. All rights reserved.
引用
收藏
页数:18
相关论文
共 50 条
  • [41] Systematic diversification of benzylidene heterocycles yields novel inhibitor scaffolds selective for Dyrk1A, Clk1 and CK2
    Mariano, Marica
    Hartmann, Rolf W.
    Engel, Matthias
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 112 : 209 - 216
  • [42] Structure-Activity Relationships of 1,2-Disubstituted Benzimidazoles: Selective Inhibition of Heme Oxygenase-2 Activity
    Kong, Xianqi
    Vukomanovic, Dragic
    Nakatsu, Kanji
    Szarek, Walter A.
    CHEMMEDCHEM, 2015, 10 (08) : 1435 - 1441
  • [43] Structure-activity relationship of clovamide and its related compounds for the inhibition of amyloid β aggregation
    Tsunoda, Tatsuhiko
    Takase, Mio
    Shigemori, Hideyuki
    BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (12) : 3202 - 3209
  • [44] Deficits in neuronal architecture but not over-inhibition are main determinants of reduced neuronal network activity in a mouse model of overexpression of Dyrk1A
    Manubens-Gil, Linus
    Pons-Espinal, Meritxell
    Gener, Thomas
    Ballesteros-Yanez, Inmaculada
    de Lagran, Maria Martinez
    Dierssen, Mara
    CEREBRAL CORTEX, 2024, 34 (01)
  • [45] FRTX-02, a selective and potent inhibitor of DYRK1A, modulates inflammatory pathways in mouse models of psoriasis and atopic dermatitis
    Kim, Soochan
    Ko, Eunhwa
    Choi, Hwan Geun
    Kim, Daekwon
    Luchi, Monica
    Khor, Bernard
    Kim, Sunghwan
    JOURNAL OF TRANSLATIONAL AUTOIMMUNITY, 2023, 6
  • [46] Structure-activity relationship of amyloid fibrils
    Maji, Samir K.
    Wang, Lei
    Greenwald, Jason
    Riek, Roland
    FEBS LETTERS, 2009, 583 (16) : 2610 - 2617
  • [47] Identification of selective dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors and their effects on tau and microtubule
    Wu, Yi-Wen
    Huangfu, Wei-Chun
    Lin, Tony Eight
    Peng, Chao-Hsiang
    Tu, Huang-Ju
    Sung, Ting-Yi
    Sung, Tzu-Ying
    Yen, Shih-Chung
    Pan, Shiow-Lin
    Hsu, Kai-Cheng
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 259
  • [48] Discovery of a novel DYRK1A inhibitor with neuroprotective activity by virtual screening and in vitro biological evaluation
    Si, Xinxin
    Qian, Chenliang
    Qiu, Nianzhuang
    Wang, Yaling
    Yao, Mingli
    Wang, Hao
    Zhang, Xuehui
    Xia, Jie
    MOLECULAR DIVERSITY, 2025, 29 (01) : 337 - 350
  • [49] How to Separate Kinase Inhibition from Undesired Monoamine Oxidase A Inhibition-The Development of the DYRK1A Inhibitor AnnH75 from the Alkaloid Harmine
    Wurzlbauer, Anne
    Rueben, Katharina
    Guerdal, Ece
    Chaikuad, Apirat
    Knapp, Stefan
    Sippl, Wolfgang
    Becker, Walter
    Bracher, Franz
    MOLECULES, 2020, 25 (24):
  • [50] Dyrk1A phosphorylates parkin at Ser-131 and negatively regulates its ubiquitin E3 ligase activity
    Im, Eunju
    Chung, Kwang Chul
    JOURNAL OF NEUROCHEMISTRY, 2015, 134 (04) : 756 - 768